한국어
English
日本語
中文(简体)
Inrevic Capsule (Fedratinib Hydrochloride Monohydrate)
117.3mg
Hard capsule · Prescription medication
(Co., Ltd.) Hanmi Pharmaceutical Co.
Fedratinib hydrochloride hydrate is an antineoplastic agent used in the treatment of hematologic malignancies.
MFDS ingredient code M282491
Fedratinib hydrochloride hydrate is an anticancer ingredient used in the treatment of hematologic malignancies, particularly effective for specific blood disorders such as myelofibrosis. This ingredient works by blocking signaling pathways to inhibit the proliferation of cancer cells.
Fedratinib hydrochloride hydrate inhibits the activity of an enzyme called JAK2, blocking the signals that promote the growth and proliferation of cancer cells. This reduces the proliferation of abnormal blood cells and slows the progression of the disease.
Approved uses differ by product. Check each product's information for its actual use.
Fedratinib hydrochloride hydrate is a selective JAK2 inhibitor that is specialized for the treatment of myelofibrosis. It has distinct differences in side effect profiles and therapeutic effects compared to other JAK inhibitors.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.